Skip to main content

Table 3 CS qPCR1 application for therapy monitoring

From: Application of qPCR in conjunctival swab samples for the evaluation of canine leishmaniasis in borderline cases or disease relapse and correlation with clinical parameters

Dog ID

Day*

Left CS qPCR (par/5×104cells)

Right CS qPCR (par/5×104cells)

Left ΔCt

Right ΔCt

Therapy protocol

57

0

0.00

1.83

--

4.51

Glucantime doxycycline

17

0.00

0.00

--

--

67

0

9.36

9.80

−0.25

−0.28

Miltefosine

30

0.00

1.87

--

2.46

68

0

4.11

70.96

1.05

−3.15

Glucantime allopurinol

56

0.00

0.00

--

--

72

0

1.13

49.54

3.67

−1.77

Glucantime allopurinol

49

0.00

0.00

--

--

  1. *day 0 corresponds to initiation of therapy.